-
MLN8237 (Alisertib) for Aurora A Assays
2026-09-29
MLN8237 (Alisertib) enables selective Aurora A perturbation across cell-cycle, apoptosis, and aneugenicity workflows. This guide connects practical dosing and flow-cytometry readouts with a tiered assay strategy that separates kinase-driven chromosome missegregation from tubulin-mediated effects.
-
Cycloheximide Workflows for Translation and Apoptosis
2026-09-29
Cycloheximide provides temporal control over eukaryotic protein synthesis, making it useful for apoptosis assays, protein turnover studies, and mechanistic validation of cell-death pathways. This guide combines practical dosing, sampling, controls, and troubleshooting with assay logic inspired by recent BAK-activation research.
-
Deferasirox Fe3+ Chelate: Research Workflows
2026-09-28
Use Deferasirox Fe3+ chelate to investigate ferric-complex handling, iron biology, and myeloid-cell responses—with careful controls that distinguish a preformed iron complex from unbound deferasirox. A practical workflow connects dose and oxygen comparisons to mitochondrial ROS and differentiation readouts without treating research findings as clinical guidance.
-
Dasatinib Monohydrate: Practical Assay Design
2026-09-27
A scenario-driven guide to using Dasatinib Monohydrate (SKU B5954) in viability, proliferation, and cytotoxicity experiments. It connects kinase potency and CML research with practical stock handling, assay controls, interpretation limits, and vendor evaluation.
-
GLP-1 (9-36) amide in Receptor Signaling Research
2026-09-26
Use GLP-1 (9-36) amide to probe GLP-1 receptor signaling with a peptide antagonist, while controlling carefully for solubility and receptor cross-talk. A FRET-based cAMP workflow can help distinguish receptor-dependent effects from noncanonical glucagon activity in metabolic regulation studies.
-
(-)-Norepinephrine (+)-bitartrate in Vascular Studies
2026-09-26
Use (-)-Norepinephrine (+)-bitartrate to probe adrenergic responses in vascular assays, from receptor-focused in vitro work to sepsis-related renal perfusion models. A study of septic rats shows why agonist responses should be interpreted alongside vascular-bed, disease-stage, and potassium-channel context.
-
Cardamomin Limits Oxidative Injury in Stroke Models
2026-09-25
The study links cardamomin, a chalcone from Amomum villosum, to antioxidant signaling and regulation of oxidative-stress-associated cell death in cultured BV-2 cells and a rat cerebral ischemia model. Its findings support further investigation of cardamomin in ischemic injury research, while the preclinical models and available protocol details limit conclusions about clinical benefit or reproducibility.
-
RGFP966 and HO-1: Designing Activity Assays
2026-09-25
RGFP966 can help researchers test whether HDAC3-linked regulation influences heme oxygenase-1 biology, but it is not an HO-1 inhibitor or activity probe. This guide explains how to pair pharmacological perturbation with live-cell activity measurements while avoiding conclusions that the evidence does not support.
-
Rotigotine and Bladder Function in a Rat PD Model
2026-09-24
A 6-OHDA rat study found that rotigotine’s effects on bladder cycling depended on the administration route: subcutaneous dosing lengthened the intercontraction interval, whereas intravenous dosing shortened it at higher doses. The findings highlight a potentially important distinction between acute systemic exposure and dermal delivery, while leaving the responsible dopamine receptor subtypes and clinical relevance unresolved.
-
Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated
2026-09-24
Turn mouse-primary immunoblots, ELISAs, and tissue staining into sensitive readouts with an HRP-labeled secondary antibody. This guide connects diabetic cardiomyopathy experiments to practical assay workflows, optimization starting points, and controls for avoiding misleading signal.
-
Lenalidomide (CC-5013) Myeloma Research Workflows
2026-09-23
Build reproducible Lenalidomide assays for immune activation, TNF-alpha suppression, and anti-angiogenic research. A practical workflow also shows how to test DOT1L-immune pathway cooperation in multiple myeloma models without confusing cytotoxicity with immune reprogramming.
-
Bsa I (RNase-free): Practical Workflow Guide
2026-09-23
Bsa I (RNase-free) provides sequence-directed DNA cleavage for cloning and other DNA manipulation workflows where RNA degradation should be minimized. It is intended for molecular biology research only and should not be used for diagnostic, clinical, or medical applications.
-
MLKL Polymerization Drives Lysosomal Permeabilization
2026-09-22
The reference study identifies lysosomal membrane permeabilization as a direct consequence of MLKL polymerization during necroptosis, connecting necrosome activation to cathepsin release and proteolytic cell death. Its combined imaging, polymerization, inhibition, and knockdown experiments provide a framework for testing lysosomal cathepsin B as an execution-stage mediator rather than a bystander marker.
-
Perphenazine: From D2 Signaling to Host Defense
2026-09-21
Perphenazine is a dopamine D2 receptor antagonist with a receptor profile that supports schizophrenia research, mitochondrial stress studies, and emerging host-directed antibacterial research. This article explains how to separate receptor pharmacology from mitochondria-mediated cell death induction and evaluate the evidence for opioid tolerance suppression and macrophage antibacterial activity.
-
ALC-0159 and the Next Logic of mRNA LNP Design
2026-09-21
A translational framework for understanding how ALC-0159 PEG lipid excipients fit into emerging strategies for improving mRNA expression, endosomal escape, tolerability, and formulation reproducibility.